Tasneem
Dohadwala
Founding Partner at Excelestar Ventures
"Technology and Equity in Life Sciences"
"Technology and Equity in Life Sciences"
Don’t miss out and join visionaries, innovators, and thought leaders from all over the world at the Women in Tech Global Conference.
Vote by Sharing
Unite 100 000 Women in Tech to Drive Change with Purpose and Impact.
Do you want to see this session? Help increase the sharing count and the session visibility. Sessions with +10 votes will be available to career ticket holders.
Please note that it might take some time until your share & vote is reflected.
Session: Technology and Equity in Life Sciences
Across the life sciences, women founders lead the charge in applying technology to close long-standing gaps in access, representation, and research equity. It’s no surprise that, from diagnostics to digital therapeutics, AI-driven tools are transforming solutions for women’s health issues as well. Tasneem Dohadwala, Founding Partner of Excelestar Ventures, will explore how emerging technologies are democratizing access to care and investment, and how female innovators are redefining inclusive innovation. Drawing on her experience at the intersection of digital health, venture investment, and biotechnology, she’ll highlight strategies to ensure that technology not only accelerates progress but also expands opportunity for underrepresented communities in science and entrepreneurship.Key Takeaways
- How emerging technologies are advancing equity and access across the life sciences
- Strategies for women founders to leverage AI and digital tools to scale innovation
- Lessons from real-world applications that bridge research, investment, and human impact
- Why inclusive innovation is essential to drive sustainable progress in health and biotech
Bio
Tasneem Dohadwala is the Founding Partner of Excelestar Ventures, focused on promising investments in medical and deep technology. Her prior experience includes positions at Lehman Brothers and Matrix Partners. Notable investments at Excelestar include Augmenix and nVision, both acquired by Boston Scientific. Under her leadership, Excelestar Ventures was recognized by The Boston Globe as one of the Top 100 Women-Led Businesses in Massachusetts. Tasneem serves as Managing Partner of the Golden Seeds Boston Chapter and is a graduate of Wellesley College and Harvard Business School.